Corrigendum: Validation of single nucleotide variant assays for human leukocyte antigen haplotypes HLA-B*15:02 and HLA-A*31:01 across diverse ancestral backgrounds

Corrigendum: Validation of single nucleotide variant assays for human leukocyte antigen haplotypes HLA-B15:02 and HLA-A31:01 across diverse ancestral backgrounds

Bibliographic Details
Main Authors:	Amanda Buchner, Xiuying Hu, Katherine J. Aitchison
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Pharmacology
Subjects:	HLA antigens adverse drug reactions carbamazepine psychiatry pharmacogenetics precision medicine
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.971316/full

Similar Items

Validation of Single Nucleotide Variant Assays for Human Leukocyte Antigen Haplotypes HLA-B*15:02 and HLA-A*31:01 Across Diverse Ancestral Backgrounds
by: Amanda Buchner, et al.
Published: (2021-07-01)

Single Nucleotide Variants as Proxies for HLA-A*31:01 in Native American Populations
by: Vanessa Câmara Fernandes, et al.
Published: (2022-04-01)

A Screening Test for HLA-B∗15:02 in a Large United States Patient Cohort Identifies Broader Risk of Carbamazepine-Induced Adverse Events
by: Hua Fang, et al.
Published: (2019-03-01)

HLA-B*57:01/Carbamazepine-10,11-Epoxide Association Triggers Upregulation of the NFκB and JAK/STAT Pathways
by: Funmilola Josephine Haukamp, et al.
Published: (2023-02-01)

The Mechanistic Differences in HLA-Associated Carbamazepine Hypersensitivity
by: Gwendolin S. Simper, et al.
Published: (2019-10-01)

Distribution of HLA-B Alleles and Haplotypes in Qatari: Recommendation for Establishing Pharmacogenomic Markers Screening for Drug Hypersensitivity
by: Mohammed Dashti, et al.
Published: (2022-08-01)

Diversity in the HLA-I Recognition of HLA-F Monoclonal Antibodies: HLA-F or HLA-Ib Monospecific, HLA-E or HLA-G Bispecific Antibodies with or without HLA-Ia Reactivity
by: Mepur H. Ravindranath, et al.
Published: (2024-01-01)

Nasopharyngeal Carcinoma (NPC) Related Human Leukocyte Antigen (HLA) Haplotype Sharing among Southern East Asian Population
by: Rika Yuliwulandari, et al.
Published: (2017-02-01)

Editorial: Precision psychiatry from a pharmacogenetics perspective
by: Lisa C. Brown, et al.
Published: (2023-03-01)

HLA-B*5701 frequency in Chilean HIV-infected patients and in general population
by: Helena Poggi, et al.

Implementation of HLA-B*15:02 Genotyping as Standard-of-Care for Reducing Carbamazepine/Oxcarbazepine Induced Cutaneous Adverse Drug Reactions in Thailand
by: Kanyawan Tiwattanon, et al.
Published: (2022-07-01)

Repurposing HLA genotype data of renal transplant patients to prevent severe drug hypersensitivity reactions
by: Lisanne E. N. Manson, et al.
Published: (2023-10-01)

Ramifications of the HLA-I Allelic Reactivity of Anti-HLA-E*01:01 and Anti-HLA-E*01:03 Heavy Chain Monoclonal Antibodies in Comparison with Anti-HLA-I IgG Reactivity in Non-Alloimmunized Males, Melanoma-Vaccine Recipients, and End-Stage Renal Disease Patients
by: Mepur H. Ravindranath, et al.
Published: (2022-03-01)

Multiplexed Nanopore Sequencing of HLA-B Locus in Māori and Pacific Island Samples
by: Kim N. T. Ton, et al.
Published: (2018-04-01)

human leukocyte antigens (HLA) typing for Iraqi vitiligo patients
by: ahmed H. AL-Azzawi, et al.
Published: (2006-04-01)

Association of HLA-A*11:01, -A*24:02, and -B*18:01 with Prostate Cancer Risk: A Case-Control Study
by: Maria Antonietta Manca, et al.
Published: (2023-10-01)

HLA-B*57:01 allele prevalence in treatment-Naïve HIV-infected patients from Colombia
by: Ernesto Martínez Buitrago, et al.
Published: (2019-09-01)

Pharmacogenomics Testing Confirmation of Carbamazepine Induced DRESS Reaction of an HLA-A*31:01 Positive, Polypharmacy Patient
by: Leigh Speicher, et al.
Published: (2021-12-01)

High-Resolution Analysis Identifies High Frequency of KIR-A Haplotypes and Inhibitory Interactions of KIR With HLA Class I in Zhejiang Han
by: Sudan Tao, et al.
Published: (2021-04-01)

Allopurinol-Induced Stevens–Johnson Syndrome in Javanese Men With Positive HLA‐B*58:01
by: Astri Ferdiana, et al.
Published: (2022-06-01)

Association of HLA Alleles and HLA Haplotypes with Psoriasis, Psoriatic Arthritis and Disease Severity in a Miscegenated Population
by: Cassia FF, et al.
Published: (2021-05-01)

Genetic Diversity of HLA Class I and Class II Alleles in Thai Populations: Contribution to Genotype-Guided Therapeutics
by: Patompong Satapornpong, et al.
Published: (2020-02-01)

HLA haplotype frequencies and diversity in patients with hemoglobinopathies
by: Graziana M. Scigliuolo, et al.
Published: (2023-11-01)

HLA Diversity in Saudi Population: High Frequency of Homozygous HLA Alleles and Haplotypes
by: Aziz Alami Chentoufi, et al.
Published: (2022-06-01)

Relationship between human leukocyte antigen (HLA)-DQA1*0102/HLA-DQB1*0602 polymorphism and preeclampsia
by: Mahmoud Mohammadi, et al.
Published: (2017-09-01)

Association of Human Leukocyte Antigen (HLA) class II (DRB1 and DQB1) alleles and haplotypes with Rheumatoid Arthritis in Sudanese patients
by: Adil Ahmed Ali, et al.
Published: (2023-06-01)

HLA-B and HLA-C Differ in Their Nanoscale Organization at Cell Surfaces
by: Philippa R. Kennedy, et al.
Published: (2019-01-01)

Human Leukocyte Antigen (HLA) Influence on Prognosis of Autoimmune Hearing Loss
by: George Psillas, et al.
Published: (2021-01-01)

The HLA Ligandome Comprises a Limited Repertoire of O-GlcNAcylated Antigens Preferentially Associated With HLA-B*07:02
by: Soumya Mukherjee, et al.
Published: (2021-12-01)

HLA-targeted sequencing reveals the pathogenic role of HLA-B*15:02/HLA-B*13:01 in albendazole-induced liver failure: a case report and a review of the literature
by: Jin-Mao Liao, et al.
Published: (2023-11-01)

Analysis of HLA-A, HLA-B and HLA-DRB1 allelic frequencies in tertiary care from Telangana and Andhra Pradesh
by: Radhika Chowdary, et al.
Published: (2014-06-01)

Comportamiento de los alelos HLA-DQB1*02 y HLA-DQB1*03 en pacientes con diagnóstico presuntivo de enfermedad celíaca Behavior of HLA-DQB1*02 and HLA-DQB1*03 alleles in patients with a presumptive diagnosis of celiac disease
by: Sylvia Torres Odio, et al.
Published: (2011-09-01)

Complementarity of binding motifs is a general property of HLA-A and HLA-B molecules and does not seem to effect HLA haplotype composition
by: Xiangyu eRao, et al.
Published: (2013-11-01)

HLA-H: Transcriptional Activity and HLA-E Mobilization
by: François Jordier, et al.
Published: (2020-01-01)

<it>HLA-DQA1</it> and <it>HLA-DQB1</it> in Celiac disease predisposition: practical implications of the HLA molecular typing
by: Megiorni Francesca, et al.
Published: (2012-10-01)

Transfusion‐Related acute lung injury (TRALI) caused by antibodies to HLA‐DRB1* 07:01 and HLA‐DQB1*02:02: A case report
by: Menggentuya Huang, et al.
Published: (2023-12-01)

Prevalence of human leukocyte antigen HLA-B*57:01 in individuals with HIV in West and Central Africa
by: Malewe Kolou, et al.
Published: (2021-07-01)

Association between human leukocyte antigen (HLA) and end-stage renal disease (ESRD): a meta-analysis
by: Naila Noureen, et al.
Published: (2023-02-01)

Actual Associations between HLA Haplotype and Graves’ Disease Development
by: Katarzyna Zawadzka-Starczewska, et al.
Published: (2022-04-01)

Correlation of the two most frequent HLA haplotypes in the Italian population to the differential regional incidence of Covid-19
by: Simona Pisanti, et al.
Published: (2020-09-01)